The University of Nevada School of Medicine has been selected to participate in a nationwide, federally funded study to evaluate the effects of melatonin in promoting sleep in people diagnosed with Alzheimer's disease.
The study will compare standard and high doses of melatonin over an eight-week period. Individuals who want to participate must have a diagnosis of Alzheimer's disease, average less than seven hours of sleep at night and have a reliable caregiver.
To enroll, call registered nurse Gail Vranesh at 671-5070.
archive